SEER, INC. Contract Liability (Deferred Revenue)
SEER, INC. (SEER) had Contract Liability (Deferred Revenue) of $372.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-11
- 2026-06-30: Contract with Customer, Liability, Current $372.00K.
- 2026-03-31: Contract with Customer, Liability, Current $334.00K.
- 2025-12-31: Contract with Customer, Liability, Current $341.00K.
- 2025-09-30: Contract with Customer, Liability, Current $486.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $372.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $334.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $341.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $486.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $540.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $413.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $408.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $354.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $189.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $269.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $206.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $185.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $255.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $263.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $133.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | $325.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $429.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $394.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $376.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |